Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-guided stellate ganglion acupuncture for chronic insomnia disorder using fNIRS: study protocol for a randomized controlled trial.

Frontiers in neurology·2026
Same author

Interaction mechanism of low molecular weight fucoidan in targeting SR-A to modulate the MAPK signal pathway for the inhibition of oral leukoplakia.

International journal of biological macromolecules·2026
Same author

[Difference of autonomic responses to transcutaneous auricular vagus nerve stimulation between high-altitude and low-altitude populations].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2026
Same author

The two correlations between Academic Stress and Subjective Academic Achievement: the mediating roles of Emotion Regulation and Cognitive Decline, and the moderating role of Mind Wandering.

Frontiers in psychology·2026
Same author

Phase angle as a prognostic nutritional marker for survival in nasopharyngeal carcinoma patients undergoing chemoradiotherapy: a prospective cohort study.

Frontiers in nutrition·2026
Same author

Density-mediated freshwater plastisphere microbiomes preferentially degrade conventional rather than biodegradable microplastics.

The ISME journal·2026

Related Experiment Video

Updated: Aug 17, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K

Screening Key Pathogenic Genes and Small Molecule Compounds for PNET.

Qi Zhou1, Hao Liu2, Junsi Liu3

  • 1Scientifific Research Management Office.

Journal of Pediatric Hematology/Oncology
|December 16, 2022
PubMed
Summary

This study identifies key genes like CCNB1 and CDC20 involved in primitive neuroectodermal tumors (PNET) and suggests potential drugs, offering hope for this rare cancer.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.0K

Related Experiment Videos

Last Updated: Aug 17, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.0K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Primitive neuroectodermal tumors (PNET) are rare and aggressive malignancies with high mortality rates.
  • Understanding the molecular mechanisms driving PNET pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To identify key genes (hub genes) and molecular pathways implicated in PNET development.
  • To discover potential small molecule drug candidates for PNET treatment.

Main Methods:

  • Analysis of gene expression profiles from the Gene Expression Omnibus (GEO) database.
  • Identification of differentially expressed genes (DEGs) using Limma package in R.
  • Functional annotation (Gene Ontology, KEGG pathways) and protein-protein interaction network construction (STRING, Cytoscape).
  • Screening of potential small molecule drugs using the Connectivity Map (CMap).

Main Results:

  • Identified 468 DEGs (161 upregulated, 307 downregulated) between PNET and normal samples.
  • Enriched Gene Ontology terms included mitosis, nuclear division, and cytoskeleton-related functions.
  • Key pathways associated with PNET include DNA replication, cell cycle, and synaptic vesicle cycle.
  • Five hub genes (CCNB1, CDC20, KIF11, KIF2C, MAD2L1) were identified as potential biomarkers.
  • Seven small molecule compounds (e.g., trichostatin A, luteolin, vorinostat) were identified as potential therapeutic candidates.

Conclusions:

  • CCNB1, CDC20, KIF11, KIF2C, and MAD2L1 are critical hub genes in PNET pathogenesis.
  • The identified small molecules show promise for future PNET drug development.
  • This research provides valuable insights into PNET molecular mechanisms and potential therapeutic strategies.